These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38297244)

  • 1. Variations in respiratory and functional symptoms at four months after hospitalisation due to COVID-19: a cross-sectional study.
    Fagevik Olsén M; Lannefors L; Johansson EL; Persson HC
    BMC Pulm Med; 2024 Jan; 24(1):63. PubMed ID: 38297244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study.
    Wu X; Liu X; Zhou Y; Yu H; Li R; Zhan Q; Ni F; Fang S; Lu Y; Ding X; Liu H; Ewing RM; Jones MG; Hu Y; Nie H; Wang Y
    Lancet Respir Med; 2021 Jul; 9(7):747-754. PubMed ID: 33964245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory muscle training in children and adults with neuromuscular disease.
    Silva IS; Pedrosa R; Azevedo IG; Forbes AM; Fregonezi GA; Dourado Junior ME; Lima SR; Ferreira GM
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011711. PubMed ID: 31487757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences of post-Covid patients undergoing outpatient pulmonary rehabilitation.
    Kautzky A; Nopp S; Gattinger D; Petrovic M; Antlinger M; Schomacker D; Kautzky-Willer A; Zwick RH
    Biol Sex Differ; 2024 Apr; 15(1):36. PubMed ID: 38650012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
    Huang L; Li X; Gu X; Zhang H; Ren L; Guo L; Liu M; Wang Y; Cui D; Wang Y; Zhang X; Shang L; Zhong J; Wang X; Wang J; Cao B
    Lancet Respir Med; 2022 Sep; 10(9):863-876. PubMed ID: 35568052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung function and breathing patterns in hospitalised COVID-19 survivors: a review of post-COVID-19 Clinics.
    Stockley JA; Alhuthail EA; Coney AM; Parekh D; Geberhiwot T; Gautum N; Madathil SC; Cooper BG
    Respir Res; 2021 Sep; 22(1):255. PubMed ID: 34579722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical Therapist Management of COVID-19 in the Intensive Care Unit: The West China Hospital Experience.
    Li L; Yu P; Yang M; Xie W; Huang L; He C; Gosselink R; Wei Q; Jones AYM
    Phys Ther; 2021 Jan; 101(1):. PubMed ID: 33152093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic respiratory and functional rehabilitation protocol for intensive care unit patients affected by COVID-19: a structured summary of a study protocol for a randomised controlled trial.
    Carvalho AC; Moreira J; Cubelo P; Cantista P; Branco CA; Guimarães B
    Trials; 2021 Apr; 22(1):268. PubMed ID: 33845878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
    Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
    Trials; 2021 May; 22(1):342. PubMed ID: 34001174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary and Functional Rehabilitation Improves Functional Capacity, Pulmonary Function and Respiratory Muscle Strength in Post COVID-19 Patients: Pilot Clinical Trial.
    Hockele LF; Sachet Affonso JV; Rossi D; Eibel B
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term radiological and pulmonary function abnormalities at 3 years after COVID-19 hospitalisation: a longitudinal cohort study.
    Han X; Chen L; Guo L; Wu L; Alwalid O; Liu J; Zheng Y; Chen L; Wu W; Li H; Luo Q; Zhao H; Zhang L; Bai Y; Sun B; Sun T; Gui Y; Nie T; Chen L; Yang F; Fan Y; Shi H; Zheng C
    Eur Respir J; 2024 Jul; 64(1):. PubMed ID: 38387969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung function, functional capacity, and respiratory symptoms at discharge from hospital in patients with acute pulmonary embolism: A cross-sectional study.
    Danielsbacka JS; Olsén MF; Hansson PO; Mannerkorpi K
    Physiother Theory Pract; 2018 Mar; 34(3):194-201. PubMed ID: 28937837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
    Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
    Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of respiratory tract function in healthy women in the last month of uncomplicated pregnancy].
    Sroczyński T
    Ann Acad Med Stetin; 2002; 48():331-50. PubMed ID: 14601487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.